The treatment using ADRCs for urinary incontinence
- Conditions
- Stress urinary incontinence of Post-prostatectomy
- Registration Number
- JPRN-jRCTb070200022
- Lead Sponsor
- Mukouyama Hideki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 10
(1)Patients over the age of 20
(2)Patients with post-prostatectomy stress urinary incontinence who is not able to have effect by medical treatments
(3)Post-prostatectomy patients who have not had a recurrence of prostate cancer in two years
(4)Patients who have provided a written informed consent to participate in this research
(5)Patient who has sufficient amount of adipose in the area of abdomen, lumber, or femoral region. This is to be confirmed by CT Scan (Plain/Supine Position) where adipose is to be collected.
(1)Patients with infectious diseases
(2)Patients with fever symptoms
(3)Patients with severe complications; heart disease, pulmonary disease, liver disease, kidney disease (creatinine 3.0 and above), bleeding tendency, severe anemia, uncontrolled diabetes, high blood pressure
(4)Patients who are currently on a large amount of steroids or immunosuppressive agents
(5)Patients with past medical history of drug hypersensitivity
(6)Patients with malignant tumors who are receiving chemotherapy, radiation therapy, and other cancer treatments.
(7)Patients who are not able to be evaluated properly due to cognitive problems
(8)Patients who are carriers of either HBV, HCV, HIV, and HTLV-1 or who are already at onset of the disease.(excluding cured pre-infected patients)
(9)Patients who are determined unfit for the treatment by principal investigator or sub investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety for 52 weeks of post cell transplantation<br>Macroscopic observation (infection, local lesion, presence or absence of tumor mass), observation of general condition
- Secondary Outcome Measures
Name Time Method Changes in urine volumes of a 24 hours pad test in comparison with pre-transplantation value against post transplantation at 4 weeks, 12 weeks, 24 weeks, 52 weeks. (Volume, and decreasing rate)<br>QOL Survey(King Health Questionnaire Sheet)<br>Safety of post transplantation up to 52 weeks